I am the FIRST!!!
regular 4 post ff
infinite scroll 4 pff
Aug. 23, 2021 02:26PM EST
Valuations for venture-backed companies at record highs
Valuations for U.S. venture-backed companies are at record highs, per data released this morning by PitchBook.
Between the lines: It's the new normal, in which nontraditional investors are traditional, unicorns are pigeons and startups are in the driver's seat.
Inside the numbers: Valuation creep can be seen across all stages of the VC ecosystem, from seed to pre-IPO. It's also showing up in both the medians and averages, and also across quartiles, reflecting how this isn't just a few big deals skewing the data.
- Early-stage valuations hit all-time records in Q2 2021 of $50 million (median) and $105.4 million (average).
- Late-stage valuations also hit new highs, with the trendline suggesting that average late-stage valuations could top $1 billion by year-end.
- Value hunting: Deals in the four major tech hubs of SF, NYC, LA and Boston remain more expensive than deals elsewhere in the U.S.
What's happening: Most of this is just animal spirits running rampant, with price discipline now viewed as passé. Plus a ton of crossover money seeking yield and public equity markets forcing a reverse denominator effects on LP bankrolls.
- This often means that funds are owning smaller percentages of their portfolio companies, with average late-stage stakes falling below 20% for the first time ever.
- It's possible that a Fed taper or federal tax increases could grow valuation growth, but neither
What to watch: Fed tapering? Congress raising taxes on the wealthy? Maybe, but we've just lived through 18 months of a global pandemic that freaked out investors for all of five minutes.
- Until and unless the public markets repeatedly punch venture capitalists in the nose, forcing them to taste their own red ink, startup valuations will continue to rise. And there's no indication that's going to happen, after several years of feeling like it should happen.
Keep reading... Show less
May. 06, 2021 12:46AM EST
Lawmakers seek COVID-19 money for opioid treatment
A bipartisan trio of lawmakers is asking Treasury Secretary Janet Yellen for latitude to use some of the president’s $1.9 trillion coronavirus stimulus package for addressing the opioid crisis.
Why it matters: The opioid crisis — America's other rampant public health emergency — appears to be getting even worse, likely exacerbated by the isolation and economic effects of the COVID-19 pandemic.
- Democratic Reps. Abigail Spanberger (D-Va.) and David Trone (D-Md.), along with Republican Rep. David McKinley of West Virginia, are teaming up in the appeal.
- The three members represent areas heavily affected by opioid abuse.
The details: The American Rescue Plan, the administration's brand name for the stimulus package, passed through Congress but will ultimately be implemented by Treasury.
- The department will have great latitude to define how the money can be used and how much flexibility local governments gain to spend it.
- In a letter being sent to Yellen on Thursday morning, Spanberger, Trone and McKinley ask for flexibility to use some of the money for treatment and recovery expenses.
- "One parent told the story of how her daughter was unable to go directly into a facility that she needed to go to because of COVID exposures, so that’s been a challenge that families face," Spanberger told Axios during an interview.
Spanberger said that if the ruling does not clarify or allow for that maximum flexibility, she's prepared to introduce legislation making it clear the stimulus money can be used for addressing substance abuse.
- The congresswoman isn't concerned about the request being construed as a misappropriation of pandemic relief money because of the widespread scope of the opioid problem.
- "They may not join in the choir of why this is necessary, but they'll certainly be happy when the rest of us winnow the support," she said of possible critics.
Be smart: As the COVID-19 pandemic subsides, the opioid crisis is likely to become a broader part of the national conversation again.
- Another bipartisan group of lawmakers that includes Spanberger and Reps. Conor Lamb (D-Pa.) and Randy Feenstra (R-Iowa) introduced bipartisan legislation this week to bolster the federal response to the opioid abuse crisis.
☎️ The National Suicide Prevention Lifeline (1-800-273-8255) provides 24/7, free and confidential support for anyone in distress, in addition to prevention and crisis resources. It's also available for an online chat.
Keep reading... Show less
Mar. 23, 2021 12:58PM EST
Scientists publish criteria for diagnosing CTE in living people for first time
Scientists have produced the first consensus criteria to diagnose chronic traumatic encephalopathy (CTE) in living people.
The state of play: As of now, CTE can only be diagnosed after death. But a new paper, written by over 20 scientists, is a step toward a "biomarker" that could definitively say whether a living person has the disease.
"It's a game-changer for the future. We're really not at the point of being able to diagnose CTE during life. We're getting much closer, and this new paper is an important step forward."
Robert Stern, director of clinical research at Boston University, via WashPost
Why it matters: The closer scientists get to being able to detect CTE during life, the closer the existential threat to contact sports, namely football, becomes.
- What happens when an active NFL player finds out he has CTE? Will he retire? What happens when numerous players find out?
- Scariest of all, what if a 15-year-old football player is diagnosed with CTE? Should youth football even continue?
Of note: Flag football is on the rise due to safety concerns around kids starting tackle football too early. But roughly 1.4 million kids ages 6 to 12 still played tackle as of 2018.
The backdrop: The brains of deceased NFL players like Junior Seau and Ken Stabler have been donated to science so CTE could be confirmed, and the results are alarming.
- Eye-opening stat: Ann McKee, a neuropathologist, examined the brains of 111 deceased NFL players. All but one had CTE.
- The NFL has responded by making the game safer through rule changes and equipment upgrades, and America's love affair with football has continued largely unabated.
- 71 of the 100 most-watched broadcasts of 2020 were NFL games, and just last week the league nearly doubled its already massive TV deals.
Ann McKee announces her findings on her examination of Aaron Hernandez's brain in 2017. Photo: John Tlumacki/The Boston Globe via Getty Images
Between the lines: The exact cause of CTE remains unclear, but we do know that it can be detected at an early age and spread rather quickly.
- Tyler Hilinski, the former Washington State QB who died by suicide, had Stage 1 CTE. He was 20.
- Aaron Hernandez, who killed himself in his prison cell, had Stage 3 CTE, which researchers had never seen in a brain under 46 years old. Hernandez was 27.
The big picture: As scary as CTE is to read about, that's mostly what we've done: read about it. What happens when we see it?
- The reality of this disease has been conveyed mostly through studies and tragic stories told by family members of the deceased.
- What happens when we know people who have it? What happens when we hear them talk about it and see them suffering from it?
The bottom line, via The Nation's Dave Zirin: "The days of plausible deniability — by the NFL, by players, and by fans — will be coming to a screeching halt in the next several years."
The National Suicide Prevention Lifeline (1-800-273-8255) provides 24/7, free and confidential support for anyone in distress, in addition to prevention and crisis resources. Also available for online chat.
Keep reading... Show less
Dec. 10, 2024 10:12AM EST

